7,000 Sign Up for Europe’s Largest Medical Cannabis Trial
The cost of the medications has been capped at £150 ($187 dollars US) per month for the participants – a price roughly equivalent to what consumers pay in the country’s illicit market.
Sapphire Medical Clinics Launches Medical Cannabis Education Service for UK Doctors and Patients
The platform will include free educational webinars that cover the latest evidence for medical cannabis treatments, dosing and monitoring, modes of administration, and key case study examples.
The ACI Launches Its Own CBD Safety Studies to Help Satisfy UK Regulators
Members of the industry group will be able to offer up their own CBD products for safety tests, which will range from contaminant analysis to experimental rodent studies.
UK Campaigners Call for More Medical Cannabis Access, Two Years on From Decision to Legalize
In an open letter to the country’s home secretary, Hannah Deacon highlights how medical cannabis remains largely unavailable to patients via the National Health Service.
Sapphire Medical Clinics Launches Registry to Expand Medical Cannabis Evidence Base in the UK
The registry aims to collect and analyze clinical information from patients taking medical cannabis treatments in the UK for all recognized eligible conditions.
Medical Cannabis Shouldn’t Always Be Considered a Last Resort, Says Review
Written by some of the country’s top drug science and policy researchers, the review puts forward a number of ‘next steps’ for the country to consider pursuing in order to better support prospective medical cannabis patients in the UK.
10 Out of 37 CBD Products Are Inaccurately Labeled, Says Nevada Lab
A partner in the testing review says the findings provide further proof that consumers should only buy from reputable CBD brands.
Researchers Believe Cannabinoids Could Treat HIV-associated Disorders
Researchers at George Mason University have received $450,000 in funding from the National Institutes of Health to pursue new research into whether cannabinoids can help treat HIV-associated disorders.
Cannabis Use During Late Pregnancy Linked to Lower Birth Weights, Study Finds
Compared with babies of mothers who had never used cannabis, infants of those who still consumed the drug after 15 weeks had lower mean values for birthweight, birth length, and head circumference.
